Annual Cash & Cash Equivalents
$2.14 M
+$1.88 M+708.80%
December 1, 2023
Summary
- As of February 8, 2025, SXTP annual cash & cash equivalents is $2.14 million, with the most recent change of +$1.88 million (+708.80%) on December 1, 2023.
- During the last 3 years, SXTP annual cash & cash equivalents has risen by +$1.95 million (+1017.63%).
- SXTP annual cash & cash equivalents is now at all-time high.
Performance
SXTP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.30 M
+$1.72 M+109.36%
September 1, 2024
Summary
- As of February 8, 2025, SXTP quarterly cash and cash equivalents is $3.30 million, with the most recent change of +$1.72 million (+109.36%) on September 1, 2024.
- Over the past year, SXTP quarterly cash and cash equivalents has increased by +$406.00 thousand (+14.03%).
- SXTP quarterly cash and cash equivalents is now at all-time high.
Performance
SXTP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SXTP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +708.8% | +14.0% |
| 3 y3 years | +1017.6% | +14.0% |
| 5 y5 years | +1017.6% | +14.0% |
SXTP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1756.6% | at high | >+9999.0% |
| 5 y | 5-year | at high | +1756.6% | at high | >+9999.0% |
| alltime | all time | at high | +1756.6% | at high | >+9999.0% |
60 Degrees Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.30 M(+109.4%) |
| Jun 2024 | - | $1.58 M(-45.5%) |
| Mar 2024 | - | $2.89 M(+35.1%) |
| Dec 2023 | $2.14 M | $2.14 M(-3.4%) |
| Sep 2023 | - | $2.22 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $19.10 K(-36.3%) |
| Mar 2023 | - | $30.00 K(-88.7%) |
| Dec 2022 | $264.90 K(+129.5%) | $264.90 K(-39.7%) |
| Sep 2022 | - | $439.40 K(+280.8%) |
| Dec 2021 | $115.40 K(-39.8%) | $115.40 K |
| Dec 2020 | $191.70 K | - |
FAQ
- What is 60 Degrees Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is 60 Degrees Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is 60 Degrees Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of SXTP is $2.14 M
What is the all time high annual cash & cash equivalents for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high annual cash & cash equivalents is $2.14 M
What is 60 Degrees Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, SXTP annual cash & cash equivalents has changed by +$1.88 M (+708.80%)
What is 60 Degrees Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SXTP is $3.30 M
What is the all time high quarterly cash and cash equivalents for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high quarterly cash and cash equivalents is $3.30 M
What is 60 Degrees Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, SXTP quarterly cash and cash equivalents has changed by +$406.00 K (+14.03%)